Delivered-To: tjphuhs@gmail.com Received: by 2002:a5d:51c9:0:b0:451:8158:aa77 with SMTP id n9csp639704wrv; Wed, 13 May 2026 13:04:51 -0700 (PDT) X-Received: by 2002:a17:90b:134b:b0:35f:bb17:39f with SMTP id 98e67ed59e1d1-36923318fc5mr778385a91.1.1778702690694; Wed, 13 May 2026 13:04:50 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1778702690; cv=none; d=google.com; s=arc-20240605; b=JNZrmbMCWwF5Js3L5gftI5EXgdg5l8EufY5SUSx/88c3VlJEo6+p1cti2rdmupZw1a eb9niXnNdePPjgbtbT44aEHnRpK1pALP6Z6pPtoLeS777AoHIk4L6PU2TXCbZthzuRAD fh9nMMfwvjFZSrLLDJSA/k3U2Ne46uM+NFR1LOpEX5r4Lu98Trg6LXluzCe1lv1wcBjd LlWtePcZsP9ynbyIIB19wfGepb/y2rl+0YgFCGu6RapgpfxP5UVuNSYiiOTwTf9TfWM9 5bpahDBH0LoriQOxdr1GKXWeZCNpx2perCY7/zy2lCQBdYLHZeg/HrSY012yg4rZII7J 2srg== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=reply-to:message-id:mime-version:list-unsubscribe-post :list-unsubscribe:list-id:from:feedback-id:date:subject:to :dkim-signature:dkim-signature; bh=neLYoMWEeNTtUhVWEukkzkJCphTVfmXz+DZ9KqXNizA=; fh=aUbTe0PB4rBmjvxO+ACBuKX8nUsE2vLi02KV92FPMDs=; b=QM5ZOpD/dXkJsHTnkDLtva5JrQO9p44T1HLfGZIQj0WWSVV1mUa0J8Hj5EBBMZ+edd panRy18MSByHfO1bY3a6NPnV/CnsBT4JKeHoZ/pZeCqp4VPelJ7CcOPtLomqVdpq2wcv Xfi1lei2Kb/ldTUQc4u6lZO7QpI4ZLY7DBBPJsXuhAMvgrAo86tnFj5c6gc4mpzupotx XHoNHn1dcN7Hq0pBNj0Sea3uFIL7rsRBK+PoCmkVDzXYOiBbQ3el0Iq004yo6+u0sr/U gSjbgPOODsaYS+teXybqtBjSHvUO75AOVUQYSJUFe9k2n/s5He5TWKjjZzbp32iS8UiX E8tQ==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@happypeps.co header.s=brevo2 header.b=RZOvXE7p; dkim=pass header.i=@mailin.fr header.s=mail header.b=KXwET8io; spf=pass (google.com: domain of bounces-m10df-info=happypeps.co@ho.d.sender-sib.com designates 77.32.148.41 as permitted sender) smtp.mailfrom="bounces-m10df-info=happypeps.co@ho.d.sender-sib.com"; dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=happypeps.co Return-Path: Received: from ho.d.sender-sib.com (ho.d.sender-sib.com. [77.32.148.41]) by mx.google.com with ESMTPS id 98e67ed59e1d1-3692fd5d8e5si182726a91.21.2026.05.13.13.04.49 for (version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256); Wed, 13 May 2026 13:04:50 -0700 (PDT) Received-SPF: pass (google.com: domain of bounces-m10df-info=happypeps.co@ho.d.sender-sib.com designates 77.32.148.41 as permitted sender) client-ip=77.32.148.41; Authentication-Results: mx.google.com; dkim=pass header.i=@happypeps.co header.s=brevo2 header.b=RZOvXE7p; dkim=pass header.i=@mailin.fr header.s=mail header.b=KXwET8io; spf=pass (google.com: domain of bounces-m10df-info=happypeps.co@ho.d.sender-sib.com designates 77.32.148.41 as permitted sender) smtp.mailfrom="bounces-m10df-info=happypeps.co@ho.d.sender-sib.com"; dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=happypeps.co DKIM-Signature: a=rsa-sha256; bh=neLYoMWEeNTtUhVWEukkzkJCphTVfmXz+DZ9KqXNizA=; c=relaxed/relaxed; d=happypeps.co; h=to:cc:from:reply-to:subject:date:mime-version:content-type:list-id:list-unsubscribe:x-csa-complaints:list-unsubscribe-post:message-id:sender:x-sib-id:x-mailin-client:x-mailin-campaign:feedback-id:bimi-selector; q=dns/txt; s=brevo2; t=1778670249; v=1; b=RZOvXE7p2u8YZRqMDBWYy0OzmfGjvUe1y2d5e4mwOLhxeadWOxz4Ov/QiB8ky3V+JaZqOmOx 3Me2TM2Q6jmd8bCAv+5ACwYF+wFpOvIdMhiyhfS3+Kzu8Bp0yaYnD9ye92sp/g43d0UBxDHMsqB /CMnzCwDPuSBqAoy7I8LMCm6x/W2u7b6P0rR7S+ZM0VUwu9mvXbW0H4mrJLIjEBaGdU75eCpYXQ AXlu1fhcqG92TqvYdSjJbW2qU1YHLXz7batHEkcSZdtTd4pTcYEIsZX6lxzYHrzeJJULMt1KVzf d/ffNwcG2z16qNfZ2irBwlh6Kl/mrtkMhRce8D1yTJQ0Q== DKIM-Signature: a=rsa-sha256; bh=neLYoMWEeNTtUhVWEukkzkJCphTVfmXz+DZ9KqXNizA=; c=relaxed/relaxed; d=mailin.fr; h=to:cc:from:reply-to:subject:date:mime-version:content-type:list-id:list-unsubscribe:x-csa-complaints:list-unsubscribe-post:message-id:sender:x-sib-id:x-mailin-client:x-mailin-campaign:feedback-id:bimi-selector; q=dns/txt; s=mail; t=1778670249; v=1; b=KXwET8ioDuoAiENrdzX/j8eOC+XH5v9Uxv+jghrv4LRWdapwI6Pmm5ZdHfi3TakP+uMMdqJg 2+dOjQGMsxkAQZwVCJKnY8+XhxwZ79pXkgv8WGDR/UyDzc4DtbL4KrYWzLQ0ihu7/Bm2a1RakUf K1ZaXrBUoJ2W+wuKQvmN+OfI= To: Subject: =?utf-8?q?=F0=9F=A7=AA_Peptide_Research_Roundup:_What=E2=80=99s_Trending_?= =?utf-8?q?in_2026?= Content-Type: multipart/alternative; boundary="-------?=_59098-6334537426094" Date: Wed, 13 May 2026 11:04:09 +0000 Feedback-ID: 77.32.148.41:10483343_90:10483343:Sendinblue From: happy peps List-Id: MTA0ODMzNDMtNzU4MS03 List-Unsubscribe: , List-Unsubscribe-Post: List-Unsubscribe=One-Click MIME-Version: 1.0 Message-Id: <202613051104.48y3iic841hrj@ho.d.sender-sib.com> Reply-To: X-Csa-Complaints: csa-complaints@eco.de X-Mailer: Sendinblue X-Mailin-Campaign: 90 X-Mailin-Client: 10483343 X-sib-id: 7boekfXv6lgGnt40P-_ZR2GAqbOd1a2ixS5LFAAFEUgCkTCSn9o_DgfOU7oPmerHxH72onBrZ16MU5iNtjf1wBFaZHm3YG2jTXIYnXFoFLgfbLpCNasIQdXqrVWUCADwDhMcHdd4s1LGO5LJ84GuJZYr5i5F-jubBNJQq3bb-KcnxhesXLayLIpPR0gxUoqkY1rTIRPnFDP5uM0XJmvf8X0UyirUvrtwloqSubPeBPrc ---------?=_59098-6334537426094 Content-Transfer-Encoding: quoted-printable Content-Type: text/plain; charset=UTF-8 [ SHOP NOW](#top) Hello Researchers, Peptide science is moving FAST in 2026, and we wanted to share a quick roun= dup of some of the biggest trends and breakthroughs currently making waves = in the research community. =F0=9F=A7=AC **1. Oral Peptides Are Advancing** Researchers are making major progress with oral peptide delivery systems de= signed to improve absorption and stability. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsEag0y0TMTOLkXHfeGNP= d/gOkFNh2lz3oR](https://peptidestaff.com/news/oral-peptide-delivery-breakth= roughs-2026/) =E2=9A=96=EF=B8=8F **2. Next-Generation Metabolic Research Peptides** New multi-agonist peptides are becoming some of the most discussed compound= s in metabolic research. Trending names include: =E2=80=A2 Retatrutide =E2=80=A2 Amycretin =E2=80=A2 VK2735 Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsF30jAQriZJW0b73TF77= h/gdxvi4Lcc25c](https://www.investors.com/news/technology/eli-lilly-weight-= loss-drug-retatrutide-black-market/) =F0=9F=A7=A0 **3. Longevity & Mitochondrial Research** Interest continues growing around peptides connected to recovery, cellular = signaling, and healthy aging research. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsFVLRMrG4fEgGewRIDqp= l/w89CeqRfszd_](https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsFxg9= ZHeQl9qWilp7CaXp/91BJ52oNCUSJ) =F0=9F=A4=96 **4. AI-Designed Peptides** Artificial intelligence is now helping researchers predict peptide interact= ions and develop new peptide structures faster than ever before. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsGQ0rli2mr50mmbCwBKF= t/pbCl8aOEZRxk](https://arxiv.org/abs/2604.18467) =F0=9F=A7=AA **5. Peptide Stability Breakthroughs** Scientists recently discovered new enzyme technologies that may improve fut= ure peptide stability and delivery systems. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsGsLZy8R8x0B2qQalA3x= x/oW_wGSVZiS9C](https://nypost.com/2026/05/02/us-news/scientists-discover-e= nzyme-that-could-supercharge-ozempic-like-weight-loss-drugs/) =F0=9F=8F=9B=EF=B8=8F **6. Regulatory Discussions Continue** Research peptide regulations and compounding discussions remain one of the = hottest topics in the industry this year. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsHKgIAYpV2vLIuFya8ng= 1/1vRIEc35IkPf](https://www.allure.com/story/fda-peptide-ban-reversal) =F0=9F=93=88 **7. The Peptide Industry Keeps Growing** The peptide market continues expanding rapidly as interest in metabolic, lo= ngevity, and recovery research grows worldwide. Read more: [https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/1t6Af4OiGsHn10MzDr8qVYy5MP7XO= 5/v7nogfulCMpd](https://www.axios.com/2026/04/23/rfk-peptide-push-glp1-well= ness-boom) **Thank you for being part of the research community with us.** **=E2=80=94 HappyPeps [https://happypeps.co](https://m10df.r.ag.d.sendibm3.com/mk/cl/f/sh/7nVU1aA= 2nfsZpYhztZtx9hNQNzY4lxB/GUgXq2_EgSDU)** **For Research Use Only. Not for Human Consumption.** ---------?=_59098-6334537426094 Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset=UTF-8 =F0=9F=A7=AA Peptide Research= Roundup: What=E2=80=99s Trending in 2026
AI-designed peptides, oral delivery research, GLP advancements & th= e latest trends shaping peptide science.‌   ­‌   &s= hy;‌   ­‌   ­‌   ­‌   &= shy;‌   ­‌   ­‌   ­‌   = ­‌   ­‌   ­‌   ­‌  = ­‌   ­‌   ­‌   ­‌  = ; ­‌   ­‌   ­‌   ­‌ &nbs= p; ­‌   ­‌   ­‌   ­‌ &nb= sp; ­‌   ­‌   ­‌   ­‌ &n= bsp; ­‌   ­‌   ­‌   ­‌ &= nbsp; ­‌   ­‌   ­‌   ­‌ =   ­‌   ­‌   ­‌   ­‌=   ­‌   ­‌   ­‌   ­&zwnj= ;   ­‌   ­‌   ­‌   ­&zwn= j;   ­‌   ­‌   ­‌   ­&zw= nj;   ­‌   ­‌   ­‌   ­&z= wnj;   ­‌   ­‌   ­‌   ­&= zwnj;   ­‌   ­‌   ­‌   ­= ‌   ­‌   ­‌   ­‌   ­= ;‌   ­‌   ­‌   ­‌   &sh= y;‌   ­‌   ­‌   ­‌   &s= hy;‌   ­‌   ­‌   ­‌   &= shy;‌   ­‌   ­‌   ­‌   = ­‌   ­‌   ­‌   ­‌  = ­‌   ­‌   ­‌   ­‌  = ; ­‌   ­‌   ­‌   ­‌ &nbs= p; ­‌   ­‌   ­‌   ­‌ &nb= sp; ­‌   ­‌   ­‌   ­‌ &n= bsp; ­‌   ­‌   ­‌   ­‌ &= nbsp; ­‌   ­‌   ­‌   ­‌ =   ­‌   ­‌   ­‌   ­‌=   ­‌   ­‌   ­‌   ­&zwnj= ;   ­‌   ­‌   ­‌   ­&zwn= j;   ­‌   ­‌   ­‌   ­&zw= nj;   ­‌   ­‌   ­‌   ­&z= wnj;   ­‌   ­‌   ­‌   ­&= zwnj;   ­‌   ­‌   ­‌   ­= ‌   ­‌   ­‌   ­‌   ­= ;‌   ­‌   ­‌   ­‌   &sh= y;‌   ­‌   ­‌   ­‌   &s= hy;‌   ­‌   ­‌   ­‌   &= shy;‌   ­‌   ­‌   ­‌   = ­‌   ­‌   ­‌   ­‌  = ­‌   ­‌   ­‌   ­‌  = ; ­‌   ­‌   ­‌   ­‌ &nbs= p; ­‌   ­‌   ­‌   ­‌ &nb= sp; ­‌   ­‌   ­‌   ­‌ &n= bsp; ­‌   ­‌   ­‌   ­‌ &= nbsp; ­‌   ­‌   ­‌   ­‌ =   ­‌   ­‌   ­‌   ­‌=   ­‌   ­‌   ­‌   ­&zwnj= ;   ­‌   ­‌   ­‌   ­&zwn= j;   ­
=
<= /tr>
<= td class=3D"r6-c" align=3D"center" style=3D"padding-bottom: 15px; padding-t= op: 15px; valign: top;"> 3D"www.happy= =
3D"www.happypeps.co"
SHOP NOW
=C2=AD
=C2=AD =C2=AD
=C2=AD


Hello Researchers,

Peptide science is moving FAST in 2026, and= we wanted to share a quick roundup of some of the biggest trends and break= throughs currently making waves in the research community.


=F0=9F=A7=AC 1. Oral Peptides Are Advancing=
Researchers are making major progress with oral peptide delivery system= s designed to improve absorption and stability.

Read more:
h= ttps://peptidestaff.com/news/oral-peptide-delivery-breakthroughs-2026/<= /p>


=E2=9A=96=EF=B8=8F 2. Next-Generation Metab= olic Research Peptides
New multi-agonist peptides are becoming = some of the most discussed compounds in metabolic research.

Trending names include:
=E2=80=A2 Retatr= utide
=E2=80=A2 Amycretin
=E2=80=A2 VK2735

Read more:
= https://www.investors.com/news/technology/eli-lilly-weight-loss-drug-retatr= utide-black-market/


=

=F0=9F=A7=A0 3. Lon= gevity & Mitochondrial Research
Interest continues growing = around peptides connected to recovery, cellular signaling, and healthy agin= g research.

Read more:
https://finance.yahoo.com/sectors/hea= lthcare/articles/formblends-publishes-2026-state-peptides-112500373.html


<= p style=3D"margin: 0; text-align: center;">=F0=9F=A4=96 4. AI-Desig= ned Peptides
Artificial intelligence is now helping researchers= predict peptide interactions and develop new peptide structures faster tha= n ever before.

Read more:https://arxiv.org/abs/2604.18467


=F0=9F=A7=AA 5. Peptide Stability Breakt= hroughs
Scientists recently discovered new enzyme technologies = that may improve future peptide stability and delivery systems.

Read more:
https://nypost.com/2026/05/02/us-news/scientists-discover-en= zyme-that-could-supercharge-ozempic-like-weight-loss-drugs/


=F0=9F=8F=9B=EF=B8=8F 6. Regulatory Discussions Contin= ue
Research peptide regulations and compounding discussions rem= ain one of the hottest topics in the industry this year.

Read more:
https://www.allure.com/story/fda-peptide-ban-reversal


=F0=9F=93=88 7. The Peptide Industry Keeps Growing<= /strong>
The peptide market continues expanding rapidly as interest in m= etabolic, longevity, and recovery research grows worldwide.

Read more:
https://www.axios.com/2026/04/23/rfk-peptide-push-glp1-wellness-= boom


Thank you for being part of the re= search community with us.

=E2=80=94 HappyPeps
https://happypeps.co

For Research Use Only. Not for Human Consumption.

 =C2=AD
=C2= =AD =C2=AD =C2=AD
If you wish to unsubscribe from our newsletter, click= here=
---------?=_59098-6334537426094--